Dexian Kong

Dexian Kong

Auto-generated profile, based on publicly available information

Dexian Kong

Department of Endocrinology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2014 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
QNQian Nie
Qian Nie
CWChao Wang
Chao Wang
GSguangyao Song
guangyao Song
HMHuijuan Ma
Huijuan Ma
DKDexian Kong
Dexian Kong
YTYong Tang
Yong Tang

2 May 2013 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
DKDexian Kong
Dexian Kong
GSGuangyao Song
Guangyao Song
CWChao Wang
Chao Wang
HMHuijuan Ma
Huijuan Ma
LRLuping Ren
Luping Ren
KGKexin Gan
Kexin Gan
Mitofusin 2 (Mfn2) is a mitochondrial membrane protein that plays a role in mitochondrial fusion and metabolism in mammalian cells. Previous studies have reported a positive correlation between Mfn2 expression and insulin sensitivity in non‑diabetic and type 2 diabetic subjects. Thus, the aim of the present study was to investigate whether Mfn2 overexpression improves insulin sensitivity of high‑fat diet (HFD) rats and the possible underlying mechanisms. Male SD rats were randomly divided into four groups: negative control; HFD; HFD plus adenoviral vectors; and HFD plus adenoviral vectors encoding Mfn2. Following an 11‑week treatment protocol, the euglycemic‑hyperinsulinemic clamp technique was applied to evaluate insulin sensitivity in rats. The skeletal muscles from rats in each group were analyzed by real‑time PCR and western blot analysis to determine glucose transporter 4 (GLUT4) expression, translocation and relative translocation signaling. Consistent with Mfn2 repression and glucose intolerance, HFD downregulates GLUT4 expression at the mRNA and protein levels, while Mfn2 overexpression activates AMP‑activated protein kinase (AMPK), increases GLUT4 expression and translocation and improves insulin resistance in the skeletal muscles of HFD rats. Results of the present study indicate that Mfn2 overexpression improves insulin sensitivity and may regulate GLUT4 translocation in an AMPK‑dependent manner in the skeletal muscles of HFD rats. This study is likely to provide insight into the unique role of Mfn2 in promoting glucose uptake, leading to modulation of GLUT4 translocation signaling and maintenance of glucose homeostasis in vivo.

1 July 2013 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
XZXuemei Zhang
Xuemei Zhang
CWChao Wang
Chao Wang
GSguangyao Song
guangyao Song
KGKexin Gan
Kexin Gan
DKDexian Kong
Dexian Kong
LRLuping Ren
Luping Ren
Background: Increased lipid accumulation and mitochondrial dysfunction within skeletal muscle have been shown to be strongly associated with insulin resistance. However, the role of mitofusion-2 (MFN2), a key factor in mitochondrial function and energy metabolism, in skeletal muscle lipid intermediate accumulation remains to be elucidated. Results: A high-fat diet resulted in insulin resistance as well as accumulation of cytosolic lipid intermediates and down-regulation of MFN2 and CPT1 in skeletal muscle in rats, while MFN2 overexpression improved insulin sensitivity and reduced lipid intermediates in muscle, possibly by upregulation of CPT1 expression. Conclusions: MFN2 overexpression can rescue insulin resistance, possibly by upregulating CPT1 expression leading to reduction in the accumulation of lipid intermediates in skeletal muscle. These observations contribute to the investigations of new diabetes therapies.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YLYabin Liu
Yabin Liu
BLBinghui Li
Binghui Li
LWLili Wang
Lili Wang
DKDexian Kong
Dexian Kong
Objective. To investigate whether the polymorphisms of interleukin‐12B (IL-12B) were associated with the risk of developing colorectal cancer (CRC). Patients and Methods. Genotypes of rs17860508 and rs3212227 were determined by polymerase chain reaction with a direct sequencing method in 329 CRC patients and 342 matched healthy control subjects. The expression of IL-12B mRNA was determined by RT‐qPCR in 50 pairs of CRC tissues and their adjacent normal tissues. Results. Compared with TTAGAG/TTAGAG genotype of rs17860508, the GC/GC and TTAGAG/GC genotypes may significantly increase the risk of CRC (OR = 1.81, 95% CI = 1.18–2.78; OR = 1.46, 95% CI = 1.01–2.12, respectively). Furthermore, the mRNA levels of IL-12B were significantly higher in the CRC tissues from patients with the rs17860508 GC/GC genotype than those with the TTAGAG/GC (P = 0.009) and TTAGAG/TTAGAG (P = 0.001) genotypes. Conclusion. These data suggested that the rs17860508 GC/GC genotype might upregulate IL-12B expression at the transcriptional level and thus increase the risk of CRC.

26 March 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YLYabin Liu
Yabin Liu
EWErqiang Wei
Erqiang Wei
JZJian Zhao
Jian Zhao
DKDexian Kong
Dexian Kong
BLBinghui Li
Binghui Li
Silencing of tumor suppressor genes by hypermethylation in gene promoter regions is a crucial mechanism in carcinogenesis. Gene methylation may be reversible and evaluated easily, thus providing a promising substrate for the development of biomarkers for the detection and prevention of cancer, including colorectal cancer (CRC). In the present study, the protein expression and methylation status of smooth muscle protein 22α (SM22α) was investigated in 78 cases of CRC and adjacent normal tissue. The aim of the study was to investigate the function of SM22α in the pathogenesis of CRC and to identify a candidate biomarker for the early detection of CRC. The methylation status of promoter of SM22α gene was detected using methylation‑specific polymerase chain reaction. The protein expression of SM22α was evaluated using western blot analysis. The results demonstrated a significant decrease of SM22α protein expression in 50 (68.5%) cases of CRC compared with that in adjacent normal tissues (P<0.001). The methylation status of SM22α promoter in CRC was significantly increased compared with that in adjacent normal tissues (P<0.001). Additionally, there was a negative correlation between the expression of SM22α protein and methylation levels of SM22α gene in CRC (P<0.001). Kaplan‑Meier curves revealed that patients with CRC with an unmethylated promoter of SM22α gene exhibited an increased survival time (34.8±0.6 vs. 30.9±1.3 months; P=0.025) compared with that in patients with a methylated promoter of SM22α gene. The present study demonstrated that the protein expression of SM22α is downregulated in CRC tissues by hypermethylation of its promoter, and that the methylation of SM22 α promoter may be used as a biomarker for early detection, prognosis and prediction of CRC.

3 June 2021 in Immunological Investigations
Verified
Journal Article
Closed access
YLYabin Liu
Yabin Liu
YDYa Duan
Ya Duan
NYNing Yang
Ning Yang
BLBinghui Li
Binghui Li
DKDexian Kong
Dexian Kong
Genetic variants in the T cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) gene have been reported to be associated with the risk of cancers and patients’ outcomes. The aims of th...